← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:863 | 863 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-988 | 69374-988-10 | Lysine Hydrochloride; Arginine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:863 | 863 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:863 | 863 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-5020 | 70214-5020-1 | Midazolam | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:863 | 863 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-16 | Morphine Sulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:863 | 863 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-611 | 81375-611-01 | Moxifloxacin Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:863 | 863 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-125 | 71449-125-11 | Neostigmine Methylsulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:863 | 863 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2529 | 72934-2529-2 | Niacinamide; Calcipotriene | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:864 | 864 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5619 | 26436-5619-3 | Estradiol 1mg/gm | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:864 | 864 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:864 | 864 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocetirizine Dihydrochloride; Clobetasol Propionate | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:864 | 864 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:864 | 864 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:864 | 864 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:864 | 864 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:864 | 864 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:864 | 864 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:864 | 864 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1212 | 73271-1212-1 | Lysine; Lidocaine; Glutamine; Arginine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:864 | 864 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:864 | 864 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-401 | 73702-401-01 | Midazolam | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:864 | 864 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-02 | Morphine Sulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:864 | 864 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-615 | 81375-615-01 | Moxifloxacin Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:864 | 864 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-161 | 82396-161-05 | Neostigmine Methylsulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:864 | 864 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-3563 | 72934-3563-8 | Niacinamide; Clindamycin Phosphate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:865 | 865 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2402 | 72627-2402-1 | Glutathione | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:865 | 865 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:865 | 865 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:865 | 865 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:865 | 865 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:865 | 865 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:865 | 865 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:865 | 865 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-05 | Midazolam | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:865 | 865 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:865 | 865 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-072 | 73198-072-30 | Magnesium Chloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:865 | 865 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5417 | 72934-5417-2 | Lidocaine; Mupirocin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:865 | 865 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-401 | 73702-401-02 | Midazolam | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:865 | 865 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-156 | 82396-156-25 | Morphine Sulfate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:865 | 865 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:865 | 865 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0329 | 83863-0329-1 | Neostigmine Methylsulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:865 | 865 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2617 | 72934-2617-8 | Niacinamide; Clobetasol Propionate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:866 | 866 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-517 | 83298-517-10 | Oxytocin | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:866 | 866 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:866 | 866 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:866 | 866 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0850 | 5446-0850-10 | Lidocaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:866 | 866 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:866 | 866 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:866 | 866 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:866 | 866 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-04 | Midazolam | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:866 | 866 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:866 | 866 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2431 | 72627-2431-1 | Magnesium Chloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:866 | 866 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5403 | 72934-5403-4 | Lidocaine; Prilocaine; Phenylephrine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:866 | 866 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:866 | 866 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate Anhydrous | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:866 | 866 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-096 | 71449-096-42 | Moxifloxacin Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:866 | 866 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:866 | 866 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2586 | 72934-2586-2 | Niacinamide; Dapsone | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:867 | 867 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-4104 | 79559-4104-1 | S-TA104 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:867 | 867 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:867 | 867 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0850 | 5446-0850-10 | Lidocaine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:867 | 867 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:867 | 867 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-720 | 70004-720-12 | Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:867 | 867 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:867 | 867 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-101 | 73177-101-06 | Ketamine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:867 | 867 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:867 | 867 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2421 | 72627-2421-1 | Methylcobalamin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:867 | 867 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5105 | 26436-5105-5 | Magnesium Chloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:867 | 867 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3150 | 72627-3150-9 | Lidocaine; Prilocaine; Phenylephrine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:867 | 867 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-130 | 71449-130-32 | Midazolam Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:867 | 867 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate Anhydrous | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:867 | 867 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8604 | 71266-8604-1 | Moxifloxacin Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:867 | 867 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-002 | 72055-002-01 | Neostigmine Methylsulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:867 | 867 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2615 | 72934-2615-2 | Niacinamide; Fluocinolone Acetonide | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:868 | 868 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-212 | 69761-212-01 | Testosterone / Anastrozole | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:868 | 868 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:868 | 868 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:868 | 868 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:868 | 868 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-723 | 70004-723-09 | Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:868 | 868 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:868 | 868 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-101 | 73177-101-02 | Ketamine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:868 | 868 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:868 | 868 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1223 | 70657-1223-3 | Methylcobalamin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:868 | 868 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0217 | 72196-0217-1 | Magnesium Chloride; Dextrose Monohydrate; Lidocaine Hydrochloride; Sodium Bicarbonate; Calcium Chloride; Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:868 | 868 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3220 | 72627-3220-9 | Lidocaine; Prilocaine; Phenylephrine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:868 | 868 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-177 | 70092-177-35 | Midazolam Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:868 | 868 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-585 | 69194-585-01 | Moxifloxacin Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:868 | 868 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:868 | 868 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-2 | Neostigmine Methylsulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:868 | 868 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1533 | 72934-1533-2 | Niacinamide; Ivermectin; Metronidazole | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:869 | 869 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5233 | 26436-5233-6 | BUTT BALM | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:869 | 869 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:869 | 869 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:869 | 869 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:869 | 869 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-949 | 69374-949-05 | Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:869 | 869 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:869 | 869 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:869 | 869 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-401 | 73702-401-02 | Midazolam | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:869 | 869 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1013 | 70657-1013-3 | Methylcobalamin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:869 | 869 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-141 | 73198-141-30 | Magnesium Chloride; Zinc Sulfate; Copper Gluconate; Manganese Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:869 | 869 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1011 | 73271-1011-1 | Lidocaine; Prilocaine; Tetracaine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:869 | 869 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:869 | 869 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:869 | 869 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8613 | 71266-8613-1 | Moxifloxacin Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:869 | 869 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-1 | Neostigmine Methylsulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:869 | 869 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1532 | 72934-1532-2 | Niacinamide; Ivermectin; Metronidazole; Brimonidine Tartrate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:870 | 870 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4600 | 72934-4600-8 | Harisis | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:870 | 870 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:870 | 870 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:870 | 870 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:870 | 870 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:870 | 870 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9070 | 71266-9070-2 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:870 | 870 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9070 | 71266-9070-2 | Ketamine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:870 | 870 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-925 | 71170-925-01 | Midazolam | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:870 | 870 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5588 | 26436-5588-1 | Methylcobalamin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:870 | 870 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0213 | 71285-0213-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:870 | 870 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1013 | 73271-1013-1 | Lidocaine; Prilocaine; Tetracaine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:870 | 870 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:870 | 870 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:870 | 870 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:870 | 870 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-9 | Neostigmine Methylsulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:870 | 870 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2525 | 72934-2525-2 | Niacinamide; Lactic Acid | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:871 | 871 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1818 | 72907-1818-3 | Triamcinolone Acetonide | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:871 | 871 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:871 | 871 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:871 | 871 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:871 | 871 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:871 | 871 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-2 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:871 | 871 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4010 | 72627-4010-9 | Ketamine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:871 | 871 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-314 | 69374-314-10 | Midazolam | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:871 | 871 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6305 | 72682-6305-1 | Methylcobalamin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:871 | 871 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0215 | 71285-0215-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:871 | 871 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1014 | 73271-1014-1 | Lidocaine; Prilocaine; Tetracaine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:871 | 871 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-418 | 70092-418-36 | Midazolam Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:871 | 871 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-501 | 81375-501-01 | Moxifloxacin Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:871 | 871 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Bromfenac Sodium | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:871 | 871 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-53 | Neostigmine Methylsulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:871 | 871 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1595 | 72934-1595-2 | Niacinamide; Levocetirizine Dihydrochloride; Imiquimod | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:872 | 872 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-104 | 70092-104-36 | Fent 2 mcg/ml-Bup 0.125% PF 100ml NS IVB | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:872 | 872 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:872 | 872 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:872 | 872 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:872 | 872 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-024 | 71449-024-07 | Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:872 | 872 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:872 | 872 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4003 | 72627-4003-7 | Ketamine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:872 | 872 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-314 | 69374-314-05 | Midazolam | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:872 | 872 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6310 | 72682-6310-1 | Methylcobalamin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:872 | 872 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0214 | 71285-0214-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:872 | 872 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1015 | 73271-1015-1 | Lidocaine; Prilocaine; Tetracaine; Phenylephrine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:872 | 872 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4356 | 72934-4356-8 | Minoxidil; Niacinamide | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:872 | 872 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-505 | 81375-505-01 | Moxifloxacin Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:872 | 872 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9034 | 83826-9034-5 | Moxifloxacin Hydrochloride; Bromfenac Sodium | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:872 | 872 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-15 | Neostigmine Methylsulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:872 | 872 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2573 | 72934-2573-2 | Niacinamide; Oxymetazoline Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:873 | 873 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2412 | 72627-2412-1 | Dexpanthenol | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:873 | 873 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Progesterone; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:873 | 873 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:873 | 873 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-2 | Lidocaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:873 | 873 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-024 | 71449-024-11 | Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:873 | 873 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 33216-779 | 33216-779-67 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:873 | 873 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4003 | 72627-4003-3 | Ketamine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:873 | 873 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:873 | 873 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:873 | 873 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0112 | 72196-0112-1 | Magnesium Sulfate Heptahydrate; Tromethamine; Dextrose Monohydrate; Sodium Chloride; Sodium Gluconate; Magnesium Chloride; Sodium Acetate; Potassium Chloride; Mannitol | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:873 | 873 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Sodium Bicarbonate | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:873 | 873 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4355 | 72934-4355-8 | Minoxidil; Progesterone | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:873 | 873 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-553 | 69194-553-01 | Moxifloxacin Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:873 | 873 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-259 | 81375-259-05 | Moxifloxacin Hydrochloride; Bromfenac Sodium | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:873 | 873 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:873 | 873 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 85933-009 | 85933-009-30 | Niacinamide; Riboflavin 5'-Phosphate Sodium Anhydrous; Pyridoxine Hydrochloride; Thiamine Hydrochloride; Dexpanthenol | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:874 | 874 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-8103 | 70168-8103-1 | Testosterone 50mg | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:874 | 874 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:874 | 874 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:874 | 874 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-3 | Lidocaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:874 | 874 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:874 | 874 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 33216-809 | 33216-809-03 | Ketamine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:874 | 874 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-103 | 73463-103-06 | Ketamine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:874 | 874 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1337 | 61141-1337-1 | Midazolam | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:874 | 874 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-051 | 73198-051-10 | Methylcobalamin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:874 | 874 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0202 | 71285-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:874 | 874 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Sodium Bicarbonate | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:874 | 874 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4348 | 72934-4348-8 | Minoxidil; Tretinoin; Fluocinolone Acetonide | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:874 | 874 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-096 | 71449-096-42 | Moxifloxacin Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:874 | 874 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:874 | 874 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:874 | 874 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1571 | 72934-1571-2 | Niacinamide; Spironolactone | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:875 | 875 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9003 | 83826-9003-5 | Timolol, Brimonidine tartrate, Dorzolamide, Bimatoprost | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:875 | 875 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estriol; Estradiol; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:875 | 875 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:875 | 875 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9090 | 71266-9090-1 | Lidocaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:875 | 875 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:875 | 875 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:875 | 875 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-100 | 73463-100-01 | Ketamine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:875 | 875 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:875 | 875 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-051 | 73198-051-30 | Methylcobalamin | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:875 | 875 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0202 | 72196-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:875 | 875 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Sodium Bicarbonate | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:875 | 875 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8515 | 71266-8515-3 | Mitomycin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:875 | 875 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-096 | 71449-096-03 | Moxifloxacin Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:875 | 875 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9004 | 83826-9004-1 | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:875 | 875 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:875 | 875 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2577 | 72934-2577-2 | Niacinamide; Tazarotene | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:876 | 876 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-370 | 73693-370-01 | ESTRADIOL 15MG | 2026-1 | valid | 0 | 2026-09-18 |